眼部基因疗法作为持续药物输送系统:药物动力学和基因动力学观点
Carmen-Ecaterina Leferman1, Alin Dumitru Ciubotaru2
1Department of Pharmacology, Grigore T. Popa University of Medicine and Pharmacy, Iasi, Romania.
Journal of medicine and life
|January 14, 2026
概括
眼部基因疗法通过使用细胞作为生物工厂,为视网膜疾病提供持续的药物输送. 这种方法克服了传统药物治疗的局限性,使单次服用后可长时间产生治疗性蛋白质.
科学领域:
- 眼科医生 眼科 眼科
- 药理学 药理学是指药理学的学科.
- 生物技术是生物技术.
背景情况:
- 眼部药物治疗面临着由于解剖障碍和快速清除的挑战,限制了后部部分的药物暴露.
- 目前的治疗方法,如内注射,导致药物水平的波动,需要经常重新治疗.
- 现有的长效系统有其局限性,例如具有有限的持续时间或依赖维护.
研究的目的:
- 审查用于持续药物输送的眼部基因治疗的药理学原则.
- 探索影响转基因表达动力学和治疗性蛋白质生产的因素.
- 为分析基因疗法暴露和指导剂量优化提供一个建模框架.
主要方法:
- 药物动力学原理与转基因表达的决定因素的整合.
- 对矢量设计,促进器架构和生物分布的分析.
- 在蛋白质输出分析中应用输入等效建模框架.
主要成果:
- 眼部基因疗法可使转化后的视网膜细胞持续在眼内产生治疗性蛋白质.
- 影响表达动学的关键因素包括载体特征,施用途径和免疫反应.
- 输液等效模型提供了预测时间到平原,稳定状态暴露和变化的参数.
结论:
- 眼部基因疗法为治疗视网膜疾病提供了一个范式转变,提供了长时间的治疗性蛋白质生产.
- 了解药理动力学和表达动力学对于优化疗效和安全至关重要.
- 未来的方向包括可调节的表达系统和基因疗法程序的基于模型的剂量优化.
相关概念视频
Drug Delivery: Overview
719
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
719
Gene Therapy
27.3K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.3K
Open Angle Glaucoma: Treatment
958
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
958
Angle Closure Glaucoma: Treatment
1.1K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.1K
Drug Delivery: Miscellaneous Routes
708
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
708
Drug Delivery: Parenteral Route
1.5K
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
1.5K


